Literature DB >> 20204336

Warfarin-flucloxacillin interaction presenting as cardioembolic ischemic stroke.

Aine Merwick, Niamh Hannon, Peter J Kelly, Killian O'Rourke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20204336     DOI： 10.1007/s00228-010-0802-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Interaction of dicloxacillin with warfarin.

Authors:  Christopher S Lacey
Journal:  Ann Pharmacother       Date:  2004-03-30       Impact factor: 3.154

2.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

3.  [Prolonged diminished effect of coumarin derivatives after use of rifampicin].

Authors:  A M Harmsze; V H M Deneer; E H Wiltink
Journal:  Ned Tijdschr Geneeskd       Date:  2007-09-01

4.  Decreased INR response secondary to warfarin-flucloxacillin interaction.

Authors:  Alka Garg; Mushtaq Mohammed
Journal:  Ann Pharmacother       Date:  2009-07-07       Impact factor: 3.154

Review 5.  Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.

Authors:  W Tang; R A Stearns
Journal:  Curr Drug Metab       Date:  2001-06       Impact factor: 3.731

Review 6.  Genetic influences on the response to warfarin.

Authors:  Farhad Kamali
Journal:  Curr Opin Hematol       Date:  2006-09       Impact factor: 3.284

Review 7.  Systematic overview of warfarin and its drug and food interactions.

Authors:  Anne M Holbrook; Jennifer A Pereira; Renee Labiris; Heather McDonald; James D Douketis; Mark Crowther; Philip S Wells
Journal:  Arch Intern Med       Date:  2005-05-23

Review 8.  Interaction between warfarin and nafcillin: case report and review of the literature.

Authors:  Karissa Y Kim; R J Frey; Kelly Epplen; Farzin Foruhari
Journal:  Pharmacotherapy       Date:  2007-10       Impact factor: 4.705

9.  Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin.

Authors:  Jörg Huwyler; Matthew B Wright; Heike Gutmann; Juergen Drewe
Journal:  Curr Drug Metab       Date:  2006-02       Impact factor: 3.731

10.  Warfarin and amoxicillin/clavulanate drug interaction.

Authors:  Liya Davydov; Marina Yermolnik; Lewis J Cuni
Journal:  Ann Pharmacother       Date:  2003-03       Impact factor: 3.154
  10 in total
  4 in total

1.  A probable clinically significant interaction between warfarin and cloxacillin: three case reports.

Authors:  Hossein Khalili; Naemeh Nikvarz; Farhad Najmeddin; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2012-09-04       Impact factor: 2.953

Review 2.  PharmVar GeneFocus: CYP2C9.

Authors:  Katrin Sangkuhl; Karla Claudio-Campos; Larisa H Cavallari; Jose A G Agundez; Michelle Whirl-Carrillo; Jorge Duconge; Andria L Del Tredici; Mia Wadelius; Mariana Rodrigues Botton; Erica L Woodahl; Stuart A Scott; Teri E Klein; Victoria M Pratt; Ann K Daly; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2021-07-12       Impact factor: 6.903

Review 3.  Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.

Authors:  Ann K Daly; Allan E Rettie; Douglas M Fowler; John O Miners
Journal:  J Pers Med       Date:  2017-12-28

4.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.